Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker

Mitochondrial serine hydroxylmethyltransferase 2 (SHMT2) is a key enzyme in the serine/glycine synthesis pathway. SHMT2 has been implicated as a critical component for tumor cell survival. The aim of the present study was to evaluate the prognostic value and efficiency of SHMT2 as a biomarker in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lahong, Chen, Zhaojun, Xue, Dan, Zhang, Qi, Liu, Xiyong, Luh, Frank, Hong, Liquan, Zhang, Hang, Pan, Feng, Liu, Yuhua, Chu, Peiguo, Zheng, Shu, Lou, Guoqiang, Yen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055214/
https://www.ncbi.nlm.nih.gov/pubmed/27666119
http://dx.doi.org/10.3892/or.2016.5112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055214/
https://www.ncbi.nlm.nih.gov/pubmed/27666119
http://dx.doi.org/10.3892/or.2016.5112

Ejemplares similares